TRM-SLE information for industry

Working with industry

Monash University has established a multi-institutional agreement with its industry partners that governs conduct of the TRM-SLE project. This includes:

• A commitment to developing an open-source instrument, following instrument development and validation.
• Representation of each industry partner on all relevant TRM-SLE committees.
• An obligation of confidentiality in relation to TRM-SLE matters.
• No requirement to share any commercially-sensitive information.

Current industry partners

Partnering with Monash University to develop the TRM-SLE instrument are:

• AbbVie Inc.
• Amgen Inc.
• AstraZeneca
• Biogen Inc.
• Bristol-Myers Squibb
• Eli Lilly and Company
• Genentech Inc.
• GSK
• Janssen Research & Development, LLC (a Johnson & Johnson Company)
• Merck (the Healthcare business of Merck operates as EMD Serono in the U.S. and Canada)
• Novartis
• Takeda Development Center Americas, Inc.
• UCB

New partners

The TRM-SLE Taskforce is open to new industry partners.

Contact us

To express interest in becoming a TRM-SLE industry partner or for any general enquiries related to the TRM-SLE project, please contact us.